✦ LIBER ✦

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

✍ Scribed by Gabay, Cem; Emery, Paul; van Vollenhoven, Ronald; Dikranian, Ara; Alten, Rieke; Pavelka, Karel; Klearman, Micki; Musselman, David; Agarwal, Sunil; Green, Jennifer; Kavanaugh, Arthur

Book ID: 120224578
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 410 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(13)60250-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liraglutide versus glimepiride monothera

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

✍ Alan Garber; Robert Henry; Robert Ratner; Pedro A Garcia-Hernandez; Hiromi Rodri 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 267 KB

Comparison of methotrexate monotherapy w

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

✍ Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; D 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 178 KB

Clinical trial: randomized, double-blind

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4

✍ J. F. ROSSIGNOL; S. M. KABIL; Y. EL-GOHARY; A. ELFERT; E. B. KEEFFE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Tocilizumab inhibits structural joint da

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

✍ Joel M. Kremer; Ricardo Blanco; Marek Brzosko; Ruben Burgos-Vargas; Anne-Marie H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 3 views

Boceprevir versus placebo with pegylated

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

✍ Sulkowski, Mark; Pol, Stanislas; Mallolas, Josep; Fainboim, Hugo; Cooper, Curtis 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 333 KB